Health

Amarin

$7.57
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.01 (+0.18%) As of 4:13 PM UTC today

Why Robinhood?

You can buy or sell Amarin and other stocks, options, and ETFs commission-free!

About AMRN

Amarin Corporation plc, also called Amarin, is a biopharmaceutical company, which focuses on the commercialization and development of therapeutics for cardiovascular health. Its product development program leverages its experience in lipid science and the potential therapeutic benefits of polyunsaturated fatty acids. It has developed and markets Vascepa capsules through wholesale. The company was founded by Geoffrey W. Guy on March 1, 1989 and is headquartered in Dublin, Ireland. The listed name for AMRN is Amarin Corporation plc.

CEO
John F. Thero
Employees
965
Headquarters
Dublin, Dublin
Founded
1989
Market Cap
2.81B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
7.80M
High Today
$7.80
Low Today
$7.31
Open Price
$7.75
Volume
4.97M
52 Week High
$20.41
52 Week Low
$3.36

Collections

AMRN Earnings

-$0.07
-$0.04
-$0.01
$0.02
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Feb 25, Pre-Market

You May Also Like

EXPGY
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure